An increased pool of CD11b+CD14−CD15+CD33+ MDSCs and decreased CD8+ T cytotoxic lymphocytes have been reported in the peripheral blood of NSCLC patients (65). This evidence concerns the gene CD8A and non-small cell lung carcinoma.